GNRH1 and ovarian hyperstimulation syndrome: Although the GnRH-ant regimen could significantly reduce the incidence of ovarian hyperstimulation syndrome (OHSS), the GnRH agonist regimen was beneficial for improving pregnancy rate and live birth rate [22, 35, 36].